Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Allergan Plc (AGN)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
[[ ctrl.chartTitle ]]
Full Chart
Realtime quote and/or trade prices are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 58,144,960
  • Shares Outstanding, K 332,580
  • Annual Sales, $ 14,571 M
  • Annual Income, $ 14,973 M
  • 36-Month Beta 1.13
  • Price/Sales 3.90
  • Price/Cash Flow 5.25
  • Price/Book 0.86

Price Performance

See More
Period Period Low Period High Performance
1-Month
169.61 +3.08%
on 11/13/17
190.71 -8.32%
on 10/23/17
-13.45 (-7.14%)
since 10/20/17
3-Month
169.61 +3.08%
on 11/13/17
237.41 -26.36%
on 09/11/17
-48.92 (-21.86%)
since 08/22/17
52-Week
169.61 +3.08%
on 11/13/17
256.80 -31.92%
on 07/25/17
-14.01 (-7.42%)
since 11/22/16

Most Recent Stories

More News
Allergan to Present at the 2017 Citi Global Healthcare Conference

Allergan plc (NYSE: AGN), a leading global biopharmaceutical company, today announced that Chief Commercial Officer William Meury will present at the 2017 Citi Global Healthcare Conference in New York...

AGN : 174.83 (+2.44%)
Asian shares advance as Wall Street regains ground

TOKYO (AP) — Asian shares edged mostly higher Tuesday after Wall Street regained lost ground overnight amid subdued trading ahead of the Thanksgiving holiday.

ZION : 46.35 (-1.15%)
TWX : 90.01 (+0.50%)
IHICY : 7.8500 (+1.42%)
MRK : 54.37 (+0.18%)
BBY : 56.49 (+0.77%)
AGN : 174.83 (+2.44%)
MRO : 14.88 (+2.48%)
HD : 172.06 (-0.46%)
MMM : 231.58 (-1.07%)
GE : 18.15 (+1.79%)
Medical Aesthetics Market Growth Continues to Shine in Healthcare Industry

Medical aesthetics is a fusion of healthcare and beauty services to provide high-technology skin care that involves significant cosmetic change or enhancement. The treatments employed include injections...

VRX.TO : 21.03 (+2.79%)
MRK : 54.37 (+0.18%)
AGN : 174.83 (+2.44%)
MLSS : 1.20 (-4.00%)
VRX : 16.54 (+3.44%)
PFE : 35.43 (-0.31%)
Leaders in Technology and Drug Development Collaborate at CNS Summit 2017 to Shape the Future of Clinical Development

Leaders in technology and drug development are meeting at CNS Summit 2017 to collaborate on initiatives and programs to shape the future of clinical development. The theme of this year's CNS Summit is...

AGN : 174.83 (+2.44%)
Allergan to Present at the Evercore ISI 2017 Biopharma Catalyst/Deep Dive Conference

Allergan plc (NYSE: AGN), a leading global biopharmaceutical company, today announced that David Nicholson, Allergan's Chief Research and Development Officer, and Armin Szegedi, Allergan's Vice President...

AGN : 174.83 (+2.44%)
Context Therapeutics Announces Senior Leadership Appointments

--Advances strategy to build pipeline of novel agents for hormone-responsive cancers

AGN : 174.83 (+2.44%)
VTAE : 21.00 (+0.05%)
Generic Drugs Stock Performance Review -- Catalyst Pharma, Flexion Therapeutics, Supernus Pharma and Allergan

If you want a Stock Review on CPRX, FLXN, SUPN, or AGN then come over to http://dailystocktracker.com/register/ and sign up for your free customized report. DailyStockTracker.com shifts focus on Catalyst...

SUPN : 39.05 (+0.90%)
AGN : 174.83 (+2.44%)
CPRX : 3.36 (+2.75%)
FLXN : 23.49 (+0.34%)
Allergan's Vraylar Gets FDA Nod for Maintenance Therapy

Allergan's (AGN) schizophrenia capsule, Vraylar, secures an FDA approval for its label expansion as a maintenance treatment option in the market.

AZN : 33.83 (+0.30%)
JNJ : 137.29 (-0.76%)
AGN : 174.83 (+2.44%)
ALKS : 50.15 (+1.59%)
Overactive Bladder Causes Significant Burden, Regardless of Age Amongst Adults

Allergan, Inc. (NYSE: AGN), in partnership with the National Association For Continence (NAFC), today announced the results of a new survey that revealed the impact of overactive bladder (OAB) and related...

AGN : 174.83 (+2.44%)
Amgen Gets Positive CHMP Opinion to Expand Nplate's Label

Amgen (AMGN) received positive CHMP opinion to expand Nplate's label to include pediatric patients and also for the marketing application of Avastin biosimilar.

AGN : 174.83 (+2.44%)
ABBV : 94.47 (-0.22%)
RHHBY : 31.6600 (+1.90%)
AMGN : 169.96 (+0.07%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Sell with a Weakest short term outlook on maintaining the current direction.

Longer term, the trend strength is Strong. Long term indicators fully support a continuation of the trend.

See More

Business Summary

Allergan, Inc. is a healthcare company. It focuses on developing and commercializing pharmaceuticals, biologics, medical devices and over-the-counter products for the ophthalmic, neurological, medical aesthetics, medical dermatology, breast aesthetics, urological and other specialty markets. Allergan...

See More

Key Turning Points

2nd Resistance Point 179.62
1st Resistance Point 177.22
Last Price 174.83
1st Support Level 171.29
2nd Support Level 167.76

See More

52-Week High 256.80
Fibonacci 61.8% 223.49
Fibonacci 50% 213.20
Fibonacci 38.2% 202.92
Last Price 174.83
52-Week Low 169.61

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart